XML 41 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Net Income Per Unrestricted Share (Tables)
9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Schedule of Calculation of Numerator and Denominator in Earnings Per Share A reconciliation of the numerator and denominator used in the calculation of Basic Net Income Per Unrestricted Share and Diluted Net Income Per Unrestricted Share for the nine and three months ended September 30, 2020 and 2019 is presented below.
 Nine Months EndedThree Months Ended
(Dollars in Millions)Sep 30,
2020
Sep 30,
2019
Sep 30,
2020
Sep 30,
2019
Net Income
$312.4 $406.4 $122.3 $129.0 
Less Net Income Attributed to Participating Awards
0.3 1.4 0.1 0.4 
Net Income Attributed to Unrestricted Shares312.1 405.0 122.2 128.6 
Dilutive Effect on Income of Equity-based Compensation Equivalent Shares
— — — — 
Diluted Net Income Attributed to Unrestricted Shares
$312.1 $405.0 $122.2 $128.6 
(Number of Shares in Thousands)  
Weighted-average Unrestricted Shares Outstanding
65,710.8 65,621.8 65,362.5 66,622.4 
Equity-based Compensation Equivalent Shares
1,086.6 719.4 1,271.0 585.3 
Weighted-average Unrestricted Shares and Equivalent Shares Outstanding Assuming Dilution
66,797.4 66,341.2 66,633.5 67,207.7 
(Per Unrestricted Share in Whole Dollars)  
Basic Net Income Per Unrestricted Share
$4.75 $6.17 $1.87 $1.93 
Diluted Net Income Per Unrestricted Share
$4.67 $6.10 $1.83 $1.91 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The number of shares of Kemper common stock that were excluded from the calculations of Equity-based Compensation Equivalent Shares and Weighted-average Unrestricted Shares and Equivalent Shares Outstanding Assuming Dilution for the nine and three months ended September 30, 2020 and 2019, because the effect of inclusion would be anti-dilutive, is presented below.
Nine Months EndedThree Months Ended
(Number of Shares in Thousands)
Sep 30,
2020
Sep 30,
2019
Sep 30,
2020
Sep 30,
2019
Equity-based Compensation Equivalent Shares
873.3 553.6 876.1 544.7 
Weighted-average Unrestricted Shares and Equivalent Shares Outstanding Assuming Dilution
873.3 553.6 876.1 544.7